Literature DB >> 8150945

Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates.

P Nordmann1, M Keller, F Espinasse, E Ronco.   

Abstract

Rhodococcus equi is a gram-positive coccobacillus that appears to be emerging as a pulmonary pathogen in AIDS patients. In four human clinical isolates, two antibiotic resistance phenotypes were found to coexist: one beta-lactam resistant and the other beta-lactam susceptible. In vitro, beta-lactam-resistant mutants were obtained at a frequency of 1 x 10(-5) to 5 x 10(-5) from beta-lactam-susceptible strains on cephalothin-containing plates. Neither beta-lactamase nor plasmid DNA was detected in beta-lactam-resistant or -susceptible strains. The penicillin-binding protein patterns for the two types of strains were identical. Electron microscopy revealed that the beta-lactam-resistant strains possessed cell-surface-associated appendages and produced phage-like particles. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of total cell protein showed at least three additional bands of 42, 39, and 30 kDa found only in the beta-lactam-resistant strains. Testing for virulence in Swiss mice revealed that (i) phage-like-particle-producing strains had lower 50% lethal doses when injected intravenously in euthymic and nude mice than the non-phage-like-particle-producing strains did and (ii) intravenous inoculation of a sublethal dose (5 x 10(6) CFU) in nude mice led to chronic infection by the phage-like-particle-producing bacteria only. Finally, in vitro growth curves indicated that the phage-like-particle-producing strains possessed an ecological selection advantage. These results suggest that, among R. equi human isolates, the antibiotic resistance phenotype is associated with virulence and may be phage mediated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150945      PMCID: PMC263039          DOI: 10.1128/jcm.32.2.377-383.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi.

Authors:  S Takai; K Koike; S Ohbushi; C Izumi; S Tsubaki
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Surface structure of in vitro assembled bacteriophage lambda polyheads.

Authors:  M Wurtz; J Kistler; T Hohn
Journal:  J Mol Biol       Date:  1976-02-15       Impact factor: 5.469

3.  Increased reproductive fitness of Escherichia coli lambda lysogens.

Authors:  L Lin; R Bitner; G Edlin
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.

Authors:  R L Harvey; J C Sunstrum
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

Review 6.  Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case.

Authors:  W Emmons; B Reichwein; D L Winslow
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

Review 7.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  A bacterial virulence determinant encoded by lysogenic coliphage lambda.

Authors:  J J Barondess; J Beckwith
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

9.  Reproductive fitness of P1, P2, and Mu lysogens of Escherichia coli.

Authors:  G Edlin; L Lin; R Bitner
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

10.  Presence of pili in species of human and animal parasites and pathogens of the genuscorynebacterium.

Authors:  R Yanagawa; E Honda
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

View more
  6 in total

1.  Genomic and functional analyses of Rhodococcus equi phages ReqiPepy6, ReqiPoco6, ReqiPine5, and ReqiDocB7.

Authors:  E J Summer; M Liu; J J Gill; M Grant; T N Chan-Cortes; L Ferguson; C Janes; K Lange; M Bertoli; C Moore; R C Orchard; N D Cohen; R Young
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

2.  Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Authors:  S Takai; K Takeda; Y Nakano; T Karasawa; J Furugoori; Y Sasaki; S Tsubaki; T Higuchi; T Anzai; R Wada; M Kamada
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.

Authors:  K V Singh; T M Coque; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Identification of intermediately virulent Rhodococcus equi isolates from pigs.

Authors:  S Takai; N Fukunaga; S Ochiai; Y Imai; Y Sasaki; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Identification of virulent Rhodococcus equi by amplification of gene coding for 15- to 17-kilodalton antigens.

Authors:  S Takai; T Ikeda; Y Sasaki; Y Watanabe; T Ozawa; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.

Authors:  Erdal Erol; Mariela Scortti; Jordan Fortner; Mukesh Patel; José A Vázquez-Boland
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.